Keywords: fda, oks, sanofi-aventis, ambien, cr, insomnia, leading

FDA OKs Sanofi-Aventis' Ambien CR for insomnia

Article | 12 September 2005

Print This

Leading French drugmaker Sanofi-Aventis says that the US Food and Drug Administration has approved its Ambien CR (zolpidem tartrate) CIV, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in